Usman Ahmad , Nura Salisu , Patricia Ishaku Kobo , Hindatu Yusuf , Ibrahim Sham’un Eshi , Dahiru Sani
{"title":"竹叶榕(Ficus abutilifolia, Miq)茎皮水提物对实验性伤寒沙门氏菌感染小鼠的体内抑菌活性","authors":"Usman Ahmad , Nura Salisu , Patricia Ishaku Kobo , Hindatu Yusuf , Ibrahim Sham’un Eshi , Dahiru Sani","doi":"10.1016/j.prenap.2025.100262","DOIUrl":null,"url":null,"abstract":"<div><div>Traditional medicine practitioners use <em>Ficus abutilifolia</em> to treat typhoid fever, chronic dysentery, and infertility. This study evaluated the antibacterial efficacy of aqueous stem bark extract of <em>Ficus abutilifolia</em> in Swiss albino mice experimentally infected with <em>Salmonella typhi</em>. Following plant identification, the stem bark extract was prepared using aqueous maceration and evaporation. Thirty mice were challenged with 1 ml containing 10<sup>3</sup>cfu/ml cells by gavage and randomly divided into six groups (n = 5). Mice in group I served as normal control, II as infected-untreated, III was treated with ciprofloxacin (14.3 mg/kg BW; positive control), IV, V, and VI were treated with oral gavage of stem bark extract at 100, 200 and 400 mg/kg, respectively, for seven consecutive days. Mean body weight and relative weight gain were calculated. Blood samples were collected for hematological examination and oxidative stress markers. The survival rate of the 400 mg/kg and ciprofloxacin-treated groups were 100 %. The 400 mg/kg-treated group exhibited the lowest bacterial load (p < 0.05) at 5.33 ± 1.52 CFU/ml by day 7 in comparison to ciprofloxacin and other treatment groups. The highest weight gain (p < 0.05) was recorded in 400 mg/kg (4.02 ± 0.01 g) in comparison to ciprofloxacin (2.67 ± 0.00 g). There was significant increase (p < 0.05) in blood profiles, with the 400 mg/kg recording RBC of 8.57 ± 0.2510<sup>9</sup>/L, PCV of 51.00 ± 2.00 %, and Hb of 8.90 ± 0.85 g/dl. The ciprofloxacin-treated group had lower RBC (10.67 ± 0.15 ˣ10<sup>9</sup>/L) and WBC counts (5.07 ± 0.1510<sup>12</sup>/L) in comparison to the infected-untreated group. There was significant increased (p < 0.05) glutathione peroxidase in 200 mg/kg (0.26 ± 0.01 U/L) and 400 mg/kg (0.26 ± 0.02 U/L) in comparison to ciprofloxacin (0.22 ± 0.01 U/L). The malondialdehyde level was significantly (p < 0.05) elevated in the infected/untreated group (46.66 ± 1.47nMol/L) in comparison to ciprofloxacin (19.06 ± 1.86nMol/L) and 400 mg/kg (16.35 ± 1.08nMol/L). <em>Ficus abutilifolia</em> extract significantly reduced bacterial load, improved hematological indices, and enhanced antioxidant response, suggesting a potential immune-modulatory effect. Given ciprofloxacin resistance concerns, <em>Ficus abutilifolia</em> may serve as a promising alternative in typhoid management.</div></div>","PeriodicalId":101014,"journal":{"name":"Pharmacological Research - Natural Products","volume":"7 ","pages":"Article 100262"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"In vivo antibacterial activities of aqueous stem bark extract of Ficus abutilifolia (Miq) in mice experimentally infected with Salmonella typhi\",\"authors\":\"Usman Ahmad , Nura Salisu , Patricia Ishaku Kobo , Hindatu Yusuf , Ibrahim Sham’un Eshi , Dahiru Sani\",\"doi\":\"10.1016/j.prenap.2025.100262\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Traditional medicine practitioners use <em>Ficus abutilifolia</em> to treat typhoid fever, chronic dysentery, and infertility. This study evaluated the antibacterial efficacy of aqueous stem bark extract of <em>Ficus abutilifolia</em> in Swiss albino mice experimentally infected with <em>Salmonella typhi</em>. Following plant identification, the stem bark extract was prepared using aqueous maceration and evaporation. Thirty mice were challenged with 1 ml containing 10<sup>3</sup>cfu/ml cells by gavage and randomly divided into six groups (n = 5). Mice in group I served as normal control, II as infected-untreated, III was treated with ciprofloxacin (14.3 mg/kg BW; positive control), IV, V, and VI were treated with oral gavage of stem bark extract at 100, 200 and 400 mg/kg, respectively, for seven consecutive days. Mean body weight and relative weight gain were calculated. Blood samples were collected for hematological examination and oxidative stress markers. The survival rate of the 400 mg/kg and ciprofloxacin-treated groups were 100 %. The 400 mg/kg-treated group exhibited the lowest bacterial load (p < 0.05) at 5.33 ± 1.52 CFU/ml by day 7 in comparison to ciprofloxacin and other treatment groups. The highest weight gain (p < 0.05) was recorded in 400 mg/kg (4.02 ± 0.01 g) in comparison to ciprofloxacin (2.67 ± 0.00 g). There was significant increase (p < 0.05) in blood profiles, with the 400 mg/kg recording RBC of 8.57 ± 0.2510<sup>9</sup>/L, PCV of 51.00 ± 2.00 %, and Hb of 8.90 ± 0.85 g/dl. The ciprofloxacin-treated group had lower RBC (10.67 ± 0.15 ˣ10<sup>9</sup>/L) and WBC counts (5.07 ± 0.1510<sup>12</sup>/L) in comparison to the infected-untreated group. There was significant increased (p < 0.05) glutathione peroxidase in 200 mg/kg (0.26 ± 0.01 U/L) and 400 mg/kg (0.26 ± 0.02 U/L) in comparison to ciprofloxacin (0.22 ± 0.01 U/L). The malondialdehyde level was significantly (p < 0.05) elevated in the infected/untreated group (46.66 ± 1.47nMol/L) in comparison to ciprofloxacin (19.06 ± 1.86nMol/L) and 400 mg/kg (16.35 ± 1.08nMol/L). <em>Ficus abutilifolia</em> extract significantly reduced bacterial load, improved hematological indices, and enhanced antioxidant response, suggesting a potential immune-modulatory effect. Given ciprofloxacin resistance concerns, <em>Ficus abutilifolia</em> may serve as a promising alternative in typhoid management.</div></div>\",\"PeriodicalId\":101014,\"journal\":{\"name\":\"Pharmacological Research - Natural Products\",\"volume\":\"7 \",\"pages\":\"Article 100262\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-05-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacological Research - Natural Products\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2950199725001223\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacological Research - Natural Products","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2950199725001223","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
In vivo antibacterial activities of aqueous stem bark extract of Ficus abutilifolia (Miq) in mice experimentally infected with Salmonella typhi
Traditional medicine practitioners use Ficus abutilifolia to treat typhoid fever, chronic dysentery, and infertility. This study evaluated the antibacterial efficacy of aqueous stem bark extract of Ficus abutilifolia in Swiss albino mice experimentally infected with Salmonella typhi. Following plant identification, the stem bark extract was prepared using aqueous maceration and evaporation. Thirty mice were challenged with 1 ml containing 103cfu/ml cells by gavage and randomly divided into six groups (n = 5). Mice in group I served as normal control, II as infected-untreated, III was treated with ciprofloxacin (14.3 mg/kg BW; positive control), IV, V, and VI were treated with oral gavage of stem bark extract at 100, 200 and 400 mg/kg, respectively, for seven consecutive days. Mean body weight and relative weight gain were calculated. Blood samples were collected for hematological examination and oxidative stress markers. The survival rate of the 400 mg/kg and ciprofloxacin-treated groups were 100 %. The 400 mg/kg-treated group exhibited the lowest bacterial load (p < 0.05) at 5.33 ± 1.52 CFU/ml by day 7 in comparison to ciprofloxacin and other treatment groups. The highest weight gain (p < 0.05) was recorded in 400 mg/kg (4.02 ± 0.01 g) in comparison to ciprofloxacin (2.67 ± 0.00 g). There was significant increase (p < 0.05) in blood profiles, with the 400 mg/kg recording RBC of 8.57 ± 0.25109/L, PCV of 51.00 ± 2.00 %, and Hb of 8.90 ± 0.85 g/dl. The ciprofloxacin-treated group had lower RBC (10.67 ± 0.15 ˣ109/L) and WBC counts (5.07 ± 0.151012/L) in comparison to the infected-untreated group. There was significant increased (p < 0.05) glutathione peroxidase in 200 mg/kg (0.26 ± 0.01 U/L) and 400 mg/kg (0.26 ± 0.02 U/L) in comparison to ciprofloxacin (0.22 ± 0.01 U/L). The malondialdehyde level was significantly (p < 0.05) elevated in the infected/untreated group (46.66 ± 1.47nMol/L) in comparison to ciprofloxacin (19.06 ± 1.86nMol/L) and 400 mg/kg (16.35 ± 1.08nMol/L). Ficus abutilifolia extract significantly reduced bacterial load, improved hematological indices, and enhanced antioxidant response, suggesting a potential immune-modulatory effect. Given ciprofloxacin resistance concerns, Ficus abutilifolia may serve as a promising alternative in typhoid management.